Literature DB >> 15759126

Thrombus and encapsulated hematoma in cerebral cavernous malformations.

Masamitsu Abe1, Kenji Fukudome, Yasuo Sugita, Tsuyoshi Oishi, Kazuo Tabuchi, Teruaki Kawano.   

Abstract

Thrombi, encapsulated hematomas, and granulation tissue are frequently seen in cerebral cavernous malformations (CCMs). We investigated the role that these histological changes play in repeated hemorrhages in CCMs as well as lesion growth, examining specimens of CCMs surgically harvested from 20 patients. The immunohistochemical study included thrombomodulin (TM) and endothelial cell protein C receptor (EPCR), which are important regulators of blood coagulation. Thick capsules, which contained blood degradation product, were seen in cases with encapsulated hematomas. Clusters of sinusoidal vessels were found outside of these thick capsules. Granulation tissue with inflammatory infiltrates and capillaries was seen in 4 cases with non-capsulated hematomas. Organizing thrombi were seen in sinusoidal vessels in 15 out of 20 cases. Factor VIII-related antigen staining demonstrated numerous capillaries in and around organizing thrombi and within the thickened vessel walls as well as in both the inner and outer sides of the hematoma capsule. TM and EPCR were positive in the endothelial cells of these capillaries, whereas they were negative in those of capillaries in the brain surrounding the lesions. Our study suggests that thrombosed sinusoidal blood vessels could gradually expand by repeated bleeding from numerous capillaries inside the wall and become encapsulated hematomas, and capillaries outside the thickened vessel wall could become sinusoidal blood vessels. Thrombosis within cerebral venules could be one of the causal factors of CCMs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759126     DOI: 10.1007/s00401-005-0994-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.

Authors:  Angeliki Louvi; Leiling Chen; Aimee M Two; Haifeng Zhang; Wang Min; Murat Günel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

2.  A "pseudo-cavernoma" - an encapsulated hematoma of the choroid plexus.

Authors:  Mahua Dey; Michael S Turner; Peter Pytel; Issam A Awad
Journal:  J Clin Neurosci       Date:  2011-03-23       Impact factor: 1.961

3.  Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions.

Authors:  Robert Shenkar; Palamadai N Venkatasubramanian; Jin-cheng Zhao; H Hunt Batjer; Alice M Wyrwicz; Issam A Awad
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

4.  Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.

Authors:  Miguel Alejandro Lopez-Ramirez; Angela Pham; Romuald Girard; Tine Wyseure; Preston Hale; Atsuki Yamashita; Janne Koskimäki; Sean Polster; Laleh Saadat; Ignacio A Romero; Charles T Esmon; Frederic Lagarrigue; Issam A Awad; Laurent O Mosnier; Mark H Ginsberg
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

5.  Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.

Authors:  Miguel Alejandro Lopez-Ramirez; Catherine Chinhchu Lai; Shady Ibrahim Soliman; Preston Hale; Angela Pham; Esau J Estrada; Sara McCurdy; Romuald Girard; Riya Verma; Thomas Moore; Rhonda Lightle; Nicholas Hobson; Robert Shenkar; Orit Poulsen; Gabriel G Haddad; Richard Daneman; Brendan Gongol; Hao Sun; Frederic Lagarrigue; Issam A Awad; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

6.  Inactivation of Cerebral Cavernous Malformation Genes Results in Accumulation of von Willebrand Factor and Redistribution of Weibel-Palade Bodies in Endothelial Cells.

Authors:  Christiane D Much; Barbara S Sendtner; Konrad Schwefel; Eric Freund; Sander Bekeschus; Oliver Otto; Axel Pagenstecher; Ute Felbor; Matthias Rath; Stefanie Spiegler
Journal:  Front Mol Biosci       Date:  2021-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.